GB0713189D0 - Amino acid derivatives - Google Patents

Amino acid derivatives

Info

Publication number
GB0713189D0
GB0713189D0 GBGB0713189.9A GB0713189A GB0713189D0 GB 0713189 D0 GB0713189 D0 GB 0713189D0 GB 0713189 A GB0713189 A GB 0713189A GB 0713189 D0 GB0713189 D0 GB 0713189D0
Authority
GB
United Kingdom
Prior art keywords
amino acid
acid derivatives
derivatives
amino
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0713189.9A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BenevolentAI Cambridge Ltd
Original Assignee
Proximagen Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Proximagen Ltd filed Critical Proximagen Ltd
Priority to GBGB0713189.9A priority Critical patent/GB0713189D0/en
Publication of GB0713189D0 publication Critical patent/GB0713189D0/en
Priority to EP08775861A priority patent/EP2176217B1/en
Priority to JP2010514127A priority patent/JP5422557B2/ja
Priority to CN200880023320.1A priority patent/CN101730678B/zh
Priority to AU2008273923A priority patent/AU2008273923B2/en
Priority to NZ583075A priority patent/NZ583075A/en
Priority to CA 2692608 priority patent/CA2692608A1/en
Priority to MX2010000150A priority patent/MX2010000150A/es
Priority to PCT/GB2008/002313 priority patent/WO2009007696A1/en
Priority to US12/667,917 priority patent/US8258097B2/en
Priority to BRPI0814800-7A2A priority patent/BRPI0814800A2/pt
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/40—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings
    • C07C271/42—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/44—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C307/00—Amides of sulfuric acids, i.e. compounds having singly-bound oxygen atoms of sulfate groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C307/02—Monoamides of sulfuric acids or esters thereof, e.g. sulfamic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/25—Sulfonic acids having sulfo groups bound to carbon atoms of rings other than six-membered aromatic rings of a carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/205—Radicals derived from carbonic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/0606—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
    • C07C2602/42—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing seven carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Psychology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Peptides Or Proteins (AREA)
GBGB0713189.9A 2007-07-06 2007-07-06 Amino acid derivatives Ceased GB0713189D0 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
GBGB0713189.9A GB0713189D0 (en) 2007-07-06 2007-07-06 Amino acid derivatives
BRPI0814800-7A2A BRPI0814800A2 (pt) 2007-07-06 2008-07-04 Derivados de aminoácidos
AU2008273923A AU2008273923B2 (en) 2007-07-06 2008-07-04 Amino acid derivatives
JP2010514127A JP5422557B2 (ja) 2007-07-06 2008-07-04 アミノ酸誘導体
CN200880023320.1A CN101730678B (zh) 2007-07-06 2008-07-04 氨基酸衍生物
EP08775861A EP2176217B1 (en) 2007-07-06 2008-07-04 Amino acid derivatives
NZ583075A NZ583075A (en) 2007-07-06 2008-07-04 Amino acid derivatives
CA 2692608 CA2692608A1 (en) 2007-07-06 2008-07-04 Amino acid derivatives
MX2010000150A MX2010000150A (es) 2007-07-06 2008-07-04 Derivados de aminoacidos.
PCT/GB2008/002313 WO2009007696A1 (en) 2007-07-06 2008-07-04 Amino acid derivatives
US12/667,917 US8258097B2 (en) 2007-07-06 2008-07-04 Amino acid derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0713189.9A GB0713189D0 (en) 2007-07-06 2007-07-06 Amino acid derivatives

Publications (1)

Publication Number Publication Date
GB0713189D0 true GB0713189D0 (en) 2007-08-15

Family

ID=38440555

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0713189.9A Ceased GB0713189D0 (en) 2007-07-06 2007-07-06 Amino acid derivatives

Country Status (11)

Country Link
US (1) US8258097B2 (enExample)
EP (1) EP2176217B1 (enExample)
JP (1) JP5422557B2 (enExample)
CN (1) CN101730678B (enExample)
AU (1) AU2008273923B2 (enExample)
BR (1) BRPI0814800A2 (enExample)
CA (1) CA2692608A1 (enExample)
GB (1) GB0713189D0 (enExample)
MX (1) MX2010000150A (enExample)
NZ (1) NZ583075A (enExample)
WO (1) WO2009007696A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6567049B2 (ja) 2014-10-21 2019-08-28 アッヴィ・インコーポレイテッド カルビドパおよびｌ−ドーパプロドラッグならびにそれらの使用方法
AU2016258179B2 (en) 2015-05-06 2021-07-01 Synagile Corporation Pharmaceutical suspensions containing drug particles, devices for their administration, and methods of their use
AU2016314617A1 (en) * 2015-09-02 2018-04-26 Cellix Bio Private Limited Compositions and methods for the treatment of parkinson's disease
EP3749677A1 (en) 2018-02-08 2020-12-16 Yissum Research Development Company of the Hebrew University of Jerusalem Ltd Dopamine precursors
CA3117983A1 (en) 2018-11-15 2020-05-22 Abbvie Inc. Pharmaceutical formulations for subcutaneous administration
BR112022003974A2 (pt) * 2019-09-05 2022-05-24 Neuroderm Ltd Composições líquidas que compreendem um conjugado de aminoácido de levodopa e seus usos

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH562199A5 (enExample) * 1970-10-30 1975-05-30 Hoffmann La Roche
JPS5422337A (en) 1977-07-18 1979-02-20 Kyowa Hakko Kogyo Co Ltd Alphamethyldopa derivatives
IT1226727B (it) * 1988-07-29 1991-02-05 Simes Farmaci precursori della dopamina.

Also Published As

Publication number Publication date
WO2009007696A1 (en) 2009-01-15
US8258097B2 (en) 2012-09-04
BRPI0814800A2 (pt) 2015-02-03
MX2010000150A (es) 2010-03-18
EP2176217B1 (en) 2012-08-22
US20100190725A1 (en) 2010-07-29
CN101730678B (zh) 2014-04-02
AU2008273923A1 (en) 2009-01-15
AU2008273923B2 (en) 2013-07-11
NZ583075A (en) 2011-08-26
CN101730678A (zh) 2010-06-09
EP2176217A1 (en) 2010-04-21
JP2010532751A (ja) 2010-10-14
CA2692608A1 (en) 2009-01-15
JP5422557B2 (ja) 2014-02-19

Similar Documents

Publication Publication Date Title
EP2116238A4 (en) Amino acid composition
PL2192109T3 (pl) Bicykliczna pochodna γ-aminokwasu
ZA201003631B (en) Isoxazolo-pyridine derivatives
IL205753A0 (en) Isoxazolo-pyridazine derivatives
IL202020A0 (en) Spiroindolinone derivatives
IL202830A0 (en) Indazolamide derivatives
ZA201001058B (en) Quinazolinamide derivatives
IL205755A0 (en) Isoxazolo-pyrazine derivatives
IL201611A0 (en) Lipoic acid derivatives
IL200618A0 (en) Aza-pyridopyrimidinone derivatives
IL202667A0 (en) Isoxazole-imidazole derivatives
PL2245028T3 (pl) Pochodne 5-aminocyklilometyloksazolidyn-2-onu
IL185790A0 (en) Amino acid derivatives
EP2133347A4 (en) 1-BIARYLAZETIDINONDERIVATE
GB0713189D0 (en) Amino acid derivatives
IL206524A0 (en) 4-dimethylminobutyric acid derivatives
IL202463A0 (en) Sulfonyl-quinoline derivatives
IL202159A0 (en) Piperidine-amide derivatives
ZA201102450B (en) Amino acid derivative
GB0715712D0 (en) Amino acid derivatives
GB0602780D0 (en) Amino Acid Derivatives
ZA201002218B (en) Thiadiazinone derivatives
GB0602799D0 (en) Non-natural amino acid derivatives
GB0711234D0 (en) Urocanic acid derivatives
EP2128136A4 (en) DERIVATIVE OF 2-PHENYLNICOTINIC ACID

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)